Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy.
about
Vaccines for preventing influenza in healthy adultsMaternal immunization. Clinical experiences, challenges, and opportunities in vaccine acceptanceReview on the effects of influenza vaccination during pregnancy on preterm birthsThe Global Influenza Initiative recommendations for the vaccination of pregnant women against seasonal influenzaMaternal immunizationImpact on pregnancies in south Brazil from the influenza A (H1N1) pandemic: cohort study.Adjuvanted A/H1N1 (2009) influenza vaccination during pregnancy: description of a prospective cohort and spontaneously reported pregnancy-related adverse reactions in the Netherlands.Evaluation of safety of A/H1N1 pandemic vaccination during pregnancy: cohort studyFetal death and preterm birth associated with maternal influenza vaccination: systematic review.Antibody response to influenza A(H1N1)pdm09 in vaccinated, serologically infected and unaffected pregnant women and their newborns.Influenza virus infection in pregnancy: a review.Maternal vaccination against H1N1 influenza and offspring mortality: population based cohort study and sibling designMaternal vaccination for the prevention of influenza: current status and hopes for the future.Risk of fetal death after pandemic influenza virus infection or vaccination.Safety and immunogenicity of 2009 pH1N1 vaccination in HIV-infected pregnant women.The PREGVAXGRIP study: a cohort study to assess foetal and neonatal consequences of in utero exposure to vaccination against A(H1N1)v2009 influenza.Altered response to A(H1N1)pnd09 vaccination in pregnant women: a single blinded randomized controlled trialCongenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety dataAssociation of influenza vaccination during pregnancy with birth outcomes in Nicaragua.The National Vaccine Advisory Committee: reducing patient and provider barriers to maternal immunizations: approved by the National Vaccine Advisory Committee on June 11, 2014Safety of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis and Influenza Vaccinations in Pregnancy.Influenza A/H1N1 MF59 adjuvanted vaccine in pregnant women and adverse perinatal outcomes: multicentre study.Perspectives on benefit-risk decision-making in vaccinology: Conference report.A systematic review of ethical issues in vaccine studies involving pregnant women.Influenza vaccination and fetal and neonatal outcomes.Prematurity and the burden of influenza and respiratory syncytial virus disease.Risk of Preterm or Small-for-Gestational-Age Birth After Influenza Vaccination During Pregnancy: Caveats When Conducting Retrospective Observational Studies.A Randomized, Blinded, Controlled, Dose-Ranging Study of a Respiratory Syncytial Virus Recombinant Fusion (F) Nanoparticle Vaccine in Healthy Women of Childbearing Age.Safety of vaccination against influenza A (H1N1) during pregnancy in the Netherlands: results on pregnancy outcomes and infant's health: cross-sectional linkage study.Peripartum outcomes: non-adjuvanted v. adjuvanted H1N1 vaccination.Selective uptake of influenza vaccine and pregnancy outcomes.Influenza H1N1 vaccination and adverse pregnancy outcome.Meeting Report: Harmonization of RSV therapeutics – from design to performanceCongenital microcephaly: Case definition & guidelines for data collection, analysis, and presentation of safety data after maternal immunisation.Fetal growth restriction: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.Gestational diabetes mellitus: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.Small for gestational age: Case definition & guidelines for data collection, analysis, and presentation of maternal immunisation safety data.Immunological Tolerance, Pregnancy, and Preeclampsia: The Roles of Semen Microbes and the Father.The impact of influenza virus infection in pregnancy.A systematic review and meta-analysis of fetal outcomes following the administration of influenza A/H1N1 vaccination during pregnancy.
P2860
Q24197955-5FBFE601-FF90-445C-BE05-39267018DF02Q26779482-B32EFC0C-BA54-4D2D-81FD-0107CD7CBA8AQ26798405-E97A3015-45D1-45D7-A889-FF128E674BFBQ26800534-C9800179-02A2-40EB-8A02-1B90D36FE6B4Q26853746-76D02C2A-55DC-4A50-AEA5-BEB9824FF773Q30359307-F23BAAE2-44D4-4FB5-990C-BFECD980D833Q30361076-79CFDF01-EBB2-44B3-8585-C7BD21462D60Q30363000-5E2419E3-4E8F-473C-95A8-94B2EB296DA1Q30364881-0A3D0D36-FB7E-488E-909A-C712163DD1F3Q30374546-925CC1B1-6B8D-4AB9-8392-D7DC4FC3F4F5Q30374989-78B8D06F-A357-4A1F-9770-012B1DA38695Q30381413-A1CAB6B1-98EB-4E00-BFF2-C4EAABB5CB86Q30386781-A2769232-98A5-417C-883A-4717BC9C716EQ30425981-0A436DD5-6119-48C0-9975-DC22EFED15A0Q30426754-7B5BF4F2-F113-4742-A421-8E54AA34E51DQ30428542-80CB4B70-B6D6-43D3-BC28-B2A71FF1F2B6Q30430043-AFA19E09-2D5F-4B44-8CE4-6E1DC204C277Q31115877-4469C14A-6080-46E7-B316-437AC4395632Q33712579-52DA18C1-DC16-4D03-BCD2-4B18498B68CBQ34576732-A1BADF41-DFAE-4B1F-A839-330A5B7B4CE6Q36201827-9FD0C608-9E2A-41B6-BA0B-F1D87F1CD33BQ36584659-2109C4A5-D619-4AEB-81C2-C9378881095BQ37130178-56649199-2AB9-4843-ABA0-8F31E52AFF58Q37197059-CF6A1ABF-51CC-4763-BA9D-EA0335494C53Q38160249-AE322DF3-C700-49F9-9C0F-4ADA7061B6D1Q38637989-5CCDA351-535F-4C41-A7BD-7E29F3105FB1Q39568699-0EFB7444-8278-4BBC-9948-52BDC7872649Q41060727-946C4AB4-4B5B-40B3-90BF-BE732E633400Q41260310-B38038EF-CDE6-4555-B7B0-F2621C311761Q42733246-A6A5286A-649A-41D7-99B3-942E689373FBQ44782956-7687E23E-5676-4CF5-8598-7A850A5164DCQ46319936-51A770CC-0E35-49D1-BC10-250059F3655EQ46622417-9FD3257E-56C1-476A-977B-88B4B631DF22Q46639978-8B32EB01-AE32-46F9-8AF8-F775B63D67E9Q47105351-7A094CE9-C8FD-418C-A0BF-12C8D8736495Q47137315-7915B213-3A42-4B2C-B666-0F52FA3D961AQ47155662-97BB4DAC-41DE-46C1-8A7E-2F7240738F1EQ47550799-D99183FD-28C6-48C5-95FA-F20D6E425EEFQ47555980-1E081DA0-4C05-49D0-8B33-CE3EDA9D5A4FQ47578103-644B10F7-6EF4-4A0B-A86E-0EB6C5C84EC1
P2860
Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Risk of adverse fetal outcomes ...... 1N1) vaccine during pregnancy.
@ast
Risk of adverse fetal outcomes ...... 1N1) vaccine during pregnancy.
@en
type
label
Risk of adverse fetal outcomes ...... 1N1) vaccine during pregnancy.
@ast
Risk of adverse fetal outcomes ...... 1N1) vaccine during pregnancy.
@en
prefLabel
Risk of adverse fetal outcomes ...... 1N1) vaccine during pregnancy.
@ast
Risk of adverse fetal outcomes ...... 1N1) vaccine during pregnancy.
@en
P2093
P50
P356
P1476
Risk of adverse fetal outcomes ...... 1N1) vaccine during pregnancy.
@en
P2093
Ditte Mølgaard-Nielsen
Hanne-Dorthe Emborg
Henrik Svanström
Tyra G Krause
P304
P356
10.1001/JAMA.2012.6131
P407
P577
2012-07-01T00:00:00Z